Drugs / PADRE-CMV fusion peptide vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00722839 | Dec 2006 → Apr 2012 | — | City of Hope Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PADRE-CMV fusion peptide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00722839 ↗ |
| Modality | Vaccine | “Peptide Vaccines” NCT00722839 ↗ |
| Route | Subcutaneous | “Given subcutaneously” NCT00722839 ↗ |